SARS-CoV-2: Finding the New Normal— A Diagnostic Perspective
Give Us Your Feedback
Changes in test volumes during coronavirus disease 2019 (COVID-19): a laboratory stewardship opportunity
Linking Statistics With Testing Policy to Manage COVID-19 in the Community
What the Protecting Access to Medicare Act Means for Clinical Laboratories.
Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.